ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 691250 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 691250; 2) Community: the network communities that were significantly associated with the response to NSC 691250; 3) Molecule: the relationships between components within communities and NSC 691250; 4) MDR: the compounds that were significantly associated with the NSC 691250.

NSC Compound Enrichment Correlation
NSC 726217 Combretastatin A4-analogue 0.00563900078161125 0.29897164
NSC 3091 Ammonium, [.alpha.-[p-(dimethylamino)phenyl]-.alpha.-[4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene]-p-tolyl]ethyldimethyl-, bromide, chloride (8CI) 0.00648124190744032 0.32166431
NSC 381866 BAFILOMYCIN DERIV. 0.00648124190744032 0.27094149
NSC 57199 3-[o-[Bis(.beta.-chloroethyl)amino]phenyl]-DL-alanine 0.00648124190744032 0.47513877
NSC 617965 Null 0.00648124190744032 0.45515727
NSC 626669 Null 0.00648124190744032 0.070118773
NSC 726444 4,11-bis[[2-(methylamino)ethyl]amino]-3-[(dimethylamino)meth yl]-1H-naphtho[2,3-f]indole-5,10-dione 0.00648124190744032 0.40092585
NSC 737518 Indenoisoquinoline derivative 0.00648124190744032 0.4340628
NSC 754241 6-(2-(dimethylamino)ethoxy)-9-methoxy-11H-indeno[1,2-c]quinolin-11-one 0.00648124190744032 0.48983233
NSC 755417 Null 0.00648124190744032 0.27090856
Total:65  Current:10    [First] [Prev] [Next] [Last]